Special Issue "Recent Non-oral Dosage Form Development: Focus on 3D-Printed Formulations"
Deadline for manuscript submissions: closed (30 July 2023) | Viewed by 7404
With the advancement of 3D printing techniques during the last decade, many new production opportunities have arisen which might also be used to produce medicinal products and drug-containing medical devices. Furthermore, the concept of individualized medicines requires the development of new production strategies in the pharmaceutical field. This is especially true for many non-oral dosage forms which are often produced in smaller batch sizes and in some cases require individualized shapes due to the anatomical variability of the site of implantation. Since many traditional concepts regarding the manufacturing but also quality control of these products cannot be directly applied, a lot of research is necessary to bring 3D printed non-oral dosage forms to the patients in the near future.
I am pleased to invite you to contribute a manuscript to the Special Issue “Recent Non-oral Dosage Form Development: Focus on 3D-Printed Formulations” of Pharmaceutics. This Special Issue aims to focus on the development of 3D printing techniques and also methods to characterize 3D printed drug-containing products in the field of non-oral medical devices and medicinal products. The dosage forms contain but are not limited to implants for different sites of administration such as classical intramuscular or subcutaneous sites but also intravitreal or further more specified sites in the human or animal body. The dosage forms may be intended exclusively for drug delivery or they might also contain a drug to be delivered to aid in the main function which is not pharmacologically, e.g., to keep a previously occluded lumen patent or to regulate foreign body reaction to a functional implant. In this Special Issue, original research articles and reviews on new aspects of 3D printing of non-oral dosage forms as well as characterization techniques or input regarding regulatory pathways are welcome.
I look forward to receiving your contributions.
Prof. Dr. Anne Seidlitz
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- 3D printing
- parenteral dosage forms
- medical devices
- medicinal products
- dosage form development
- analysis of 3D printed dosage forms
- regulation of 3D printed products